Researchers: Don’t Destroy Smallpox Virus Yet

Scientists urge the World Health Organization to delay destroying the last remaining laboratory stocks of live variola virus because there’s more research to be done.

| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

VariolaCENTERS FOR DISEASE CONTROL AND PREVENTIONAlthough smallpox was declared eradicated from the human population in 1980, some researchers have implored the World Health Assembly (WHA), the World Health Organization (WHO)’s governing body, to hold off on destroying the last known live strains of the variola virus, which causes the disease. A trio of scientists, led by Inger Damon of the US Centers for Disease Control and Prevention, argued in a PLOS Pathogens opinion published yesterday (May 1) that because synthetic biology makes it possible to recreate the virus, more research on vaccines is necessary.

“Certainly the current capabilities of synthetic biology and the availability of multiple variola virus genome sequences in the published literature make these scenarios more worrisome in the 21st century and also make the feasibility of ultimate final destruction of variola virus, itself, problematic,” Damon and her coauthors wrote.

Jimmy Kolker, Health and Human Services assistant secretary for global affairs, agreed. “The synthetic biology adds a new wrinkle to it,” he told the Associated Press. “We now aren’t as sure that our countermeasures are going to be as effective as we’d thought even five years ago.”

Two high-security labs, one in the U.S. and one in Russia, still maintain live variola virus.

Some officials—including D.A. Henderson, the researcher who led the WHO’s global smallpox eradication campaign—argued ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Keywords

Meet the Author

  • Bob Grant

    From 2017 to 2022, Bob Grant was Editor in Chief of The Scientist, where he started in 2007 as a Staff Writer.
Share
May digest 2025 cover
May 2025, Issue 1

Study Confirms Safety of Genetically Modified T Cells

A long-term study of nearly 800 patients demonstrated a strong safety profile for T cells engineered with viral vectors.

View this Issue
Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Bio-Rad
How technology makes PCR instruments easier to use.

Making Real-Time PCR More Straightforward

Thermo Fisher Logo
Characterizing Immune Memory to COVID-19 Vaccination

Characterizing Immune Memory to COVID-19 Vaccination

10X Genomics
Optimize PCR assays with true linear temperature gradients

Applied Biosystems™ VeriFlex™ System: True Temperature Control for PCR Protocols

Thermo Fisher Logo

Products

The Scientist Placeholder Image

Biotium Launches New Phalloidin Conjugates with Extended F-actin Staining Stability for Greater Imaging Flexibility

Leica Microsystems Logo

Latest AI software simplifies image analysis and speeds up insights for scientists

BioSkryb Genomics Logo

BioSkryb Genomics and Tecan introduce a single-cell multiomics workflow for sequencing-ready libraries in under ten hours

iStock

Agilent BioTek Cytation C10 Confocal Imaging Reader

agilent technologies logo